Clinical Trial Update: Travoprost 3-Month Safety and Efficacy Study [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Travoprost for safety and efficacy in open-angle glaucoma and ocular hypertension has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2013-10-18